Suppr超能文献

再灌注后立即出现的移植物功能障碍可预测活体供体肺叶移植的短期预后,但对尸体肺移植则不然。

Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.

作者信息

Mizota Toshiyuki, Miyao Mariko, Yamada Tetsu, Sato Masaaki, Aoyama Akihiro, Chen Fengshi, Date Hiroshi, Fukuda Kazuhiko

机构信息

Department of Anesthesia, Kyoto University Hospital, Kyoto, Japan

Department of Anesthesia, Kyoto University Hospital, Kyoto, Japan.

出版信息

Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):314-20. doi: 10.1093/icvts/ivv357. Epub 2015 Dec 23.

Abstract

OBJECTIVES

Primary graft dysfunction (PGD) is a major cause of early morbidity and mortality after cadaveric lung transplantation (CLT). This study examined the incidence, time course and predictive value of PGD after living-donor lobar lung transplantation (LDLLT).

METHODS

We retrospectively investigated 75 patients (42 with LDLLT and 33 with CLT) who underwent lung transplantation from January 2008 to December 2013. Patients were assigned PGD grades at six time points, as defined by the International Society for Heart and Lung Transplantation: immediately after final reperfusion, upon arrival at the intensive care unit (ICU), and 12, 24, 48 and 72 h after ICU admission.

RESULTS

The incidence of severe (Grade 3) PGD at 48 or 72 h after ICU admission was similar for LDLLT and CLT patients (16.7 vs 12.1%; P = 0.581). The majority of the LDLLT patients having severe PGD first developed PGD immediately after reperfusion, whereas more than half of the CLT patients first developed severe PGD upon ICU arrival or later. In LDLLT patients, severe PGD immediately after reperfusion was significantly associated with fewer ventilator-free days during the first 28 postoperative days [median (interquartile range) of 0 (0-10) vs 21 (13-25) days, P = 0.001], prolonged postoperative ICU stay [median (interquartile range) of 20 (16-27) vs 12 (8-14) days, P = 0.005] and increased hospital mortality (27.3 vs 3.2%, P = 0.02). Severe PGD immediately after reperfusion was not associated with ventilator-free days during the first 28 postoperative days, time to discharge from ICU or hospital, or hospital mortality in CLT patients.

CONCLUSIONS

Postoperative incidence of severe PGD was not significantly different between LDLLT and CLT patients. In LDLLT patients, the onset of severe PGD tended to be earlier than that in CLT patients. Severe PGD immediately after reperfusion was a significant predictor of postoperative morbidity and mortality in LDLLT patients but not in CLT patients.

摘要

目的

原发性移植肺功能障碍(PGD)是尸体肺移植(CLT)后早期发病和死亡的主要原因。本研究调查了活体供肺叶移植(LDLLT)后PGD的发生率、时间进程及预测价值。

方法

我们回顾性研究了2008年1月至2013年12月期间接受肺移植的75例患者(42例行LDLLT,33例行CLT)。根据国际心肺移植学会的定义,在六个时间点对患者进行PGD分级:最终再灌注后即刻、入住重症监护病房(ICU)时、入住ICU后12、24、48和72小时。

结果

入住ICU后48或72小时,LDLLT和CLT患者严重(3级)PGD的发生率相似(分别为16.7%和12.1%;P = 0.581)。大多数发生严重PGD的LDLLT患者在再灌注后即刻首次出现PGD,而超过一半的CLT患者在入住ICU时或之后首次出现严重PGD。在LDLLT患者中,再灌注后即刻发生严重PGD与术后第1个28天无呼吸机天数显著减少相关[中位数(四分位间距)为0(0 - 10)天对21(13 - 25)天,P = 0.001],术后ICU住院时间延长[中位数(四分位间距)为20(16 - 27)天对12(8 - 14)天,P = 0.005],以及医院死亡率增加(27.3%对3.2%,P = 0.02)。再灌注后即刻发生严重PGD与CLT患者术后第1个28天无呼吸机天数、从ICU或医院出院时间或医院死亡率无关。

结论

LDLLT和CLT患者术后严重PGD的发生率无显著差异。在LDLLT患者中,严重PGD的发病往往早于CLT患者。再灌注后即刻发生严重PGD是LDLLT患者术后发病和死亡的重要预测指标,但不是CLT患者的预测指标。

相似文献

2
Living-donor lobar lung transplantation provides similar survival to cadaveric lung transplantation even for very ill patients†.
Eur J Cardiothorac Surg. 2015 Jun;47(6):967-72; discussion 972-3. doi: 10.1093/ejcts/ezu350. Epub 2014 Sep 16.
4
Unilateral chronic lung allograft dysfunction is a characteristic of bilateral living-donor lobar lung transplantation.
Eur J Cardiothorac Surg. 2015 Sep;48(3):463-9. doi: 10.1093/ejcts/ezu463. Epub 2014 Dec 2.
5
Cytomegalovirus infection in living-donor and cadaveric lung transplantations.
Interact Cardiovasc Thorac Surg. 2017 Nov 1;25(5):710-715. doi: 10.1093/icvts/ivx226.
7
Native lung complications after living-donor lobar lung transplantation.
J Heart Lung Transplant. 2021 May;40(5):343-350. doi: 10.1016/j.healun.2021.01.1562. Epub 2021 Jan 24.
8
Comparison of de novo donor-specific antibodies between living and cadaveric lung transplantation.
J Heart Lung Transplant. 2021 Jul;40(7):607-613. doi: 10.1016/j.healun.2021.03.019. Epub 2021 Mar 29.
10
Bronchial healing after living-donor lobar lung transplantation.
Surg Today. 2009;39(11):938-43. doi: 10.1007/s00595-008-4049-3. Epub 2009 Nov 1.

引用本文的文献

1
Roles and practice of living-related lobar lung transplantation.
J Thorac Dis. 2023 Sep 28;15(9):5213-5220. doi: 10.21037/jtd-22-1867. Epub 2023 Jul 25.
2
Living-donor lobar lung transplantation.
J Thorac Dis. 2021 Nov;13(11):6594-6601. doi: 10.21037/jtd-2021-07.
3
Severe underweight decreases the survival rate in adult lung transplantation.
Surg Today. 2017 Oct;47(10):1243-1248. doi: 10.1007/s00595-017-1508-8. Epub 2017 Mar 17.
4
Primary graft dysfunction: pathophysiology to guide new preventive therapies.
Expert Rev Respir Med. 2017 Feb;11(2):119-128. doi: 10.1080/17476348.2017.1280398. Epub 2017 Jan 20.
5
eComment. Lung size mismatch and graft dysfunction immediately after reperfusion.
Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):320. doi: 10.1093/icvts/ivw026.

本文引用的文献

1
Living-donor lobar lung transplantation provides similar survival to cadaveric lung transplantation even for very ill patients†.
Eur J Cardiothorac Surg. 2015 Jun;47(6):967-72; discussion 972-3. doi: 10.1093/ejcts/ezu350. Epub 2014 Sep 16.
2
Postoperative respiratory management in living donor lobar lung transplantation.
Clin Transplant. 2013 Jul-Aug;27(4):E383-90. doi: 10.1111/ctr.12148. Epub 2013 Jun 11.
3
Clinical risk factors for primary graft dysfunction after lung transplantation.
Am J Respir Crit Care Med. 2013 Mar 1;187(5):527-34. doi: 10.1164/rccm.201210-1865OC. Epub 2013 Jan 10.
4
Outcomes and temporal trends among high-risk patients after lung transplantation in the United States.
J Heart Lung Transplant. 2012 Nov;31(11):1182-91. doi: 10.1016/j.healun.2012.07.001. Epub 2012 Aug 11.
5
Outcome of living-donor lobar lung transplantation using a single donor.
J Thorac Cardiovasc Surg. 2012 Sep;144(3):710-5. doi: 10.1016/j.jtcvs.2012.05.054. Epub 2012 Jun 18.
6
Construct validity of the definition of primary graft dysfunction after lung transplantation.
J Heart Lung Transplant. 2010 Nov;29(11):1231-9. doi: 10.1016/j.healun.2010.05.013. Epub 2010 Jul 22.
7
Should lung transplantation be performed for patients on mechanical respiratory support? The US experience.
J Thorac Cardiovasc Surg. 2010 Mar;139(3):765-773.e1. doi: 10.1016/j.jtcvs.2009.09.031.
8
Does anaesthetic management affect early outcomes after lung transplant? An exploratory analysis.
Br J Anaesth. 2009 Apr;102(4):506-14. doi: 10.1093/bja/aep008. Epub 2009 Feb 17.
9
Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
Am J Respir Crit Care Med. 2007 Mar 1;175(5):507-13. doi: 10.1164/rccm.200608-1079OC. Epub 2006 Dec 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验